Wed.Feb 08, 2023

article thumbnail

State of the Union: Drug Prices, Affordable Care, and Cancer A Priority for Biden Administration

Drug Topics

President Biden's 2023 State of the Union address highlighted some key areas of health care in which he hopes to make progress.

469
469
article thumbnail

Woman of the Week: KaliVir Immunotherapeutics’ Helena Chaye

PharmaVoice

The triple threat CEO — scientist, lawyer and biotech pro — thinks she’s discovered a key to curing a wide range of cancers.

239
239
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

On the Precipice of the World’s First RSV Vaccine: What’s Taking So Long?

Drug Topics

RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe, and why has vaccine development taken so long?

Vaccines 423
article thumbnail

Do masks really protect against COVID-19? Meta-analysis authors want to see more evidence

Fierce Healthcare

Do masks really protect against COVID-19?

142
142
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New Study Demonstrates Empagliflozin Effectiveness in Pediatric T2D

Drug Topics

Results of a phase 3 clinical trial represent another avenue of treatment for children and adolescents living with type 2 diabetes.

247
247
article thumbnail

Tracking the bird flu, experts see a familiar threat — and a virus whose course is hard to predict

STAT

Veteran influenza epidemiologist Keiji Fukuda remembers vividly when he first became fearful that a virulent bird flu virus, H5N1, might be on the verge of triggering a devastating pandemic. The virus, seemingly out of nowhere, did something bird flu viruses were thought not to be able to do. It infected 18 people, killing six of them. That happened in 1997, in Hong Kong.

133
133

More Trending

article thumbnail

Black History Month: Pharmacy Trailblazers

Pharmacy Is Right For Me

February marks Black History Month in the United States. We want to take this opportunity to recognize some Black pharmacists who have made significant contributions to the pharmacy field. James McCune Smith James McCune Smith was born into slavery in 1813. He earned his medical degree from Glasgow University. He is recognized as the first African American to earn a medical degree, the first to be published in American medical journals, as well as the first African American to own and operate a

article thumbnail

Managing Wintertime Psoriasis Flares

Drug Topics

Long, hot showers and cold, dry air can contribute to psoriasis flare-ups during the winter months.

190
190
article thumbnail

The unique playbook of Biohaven’s CEO

PharmaVoice

Vlad Coric’s offbeat business strategy paid off once with a Pfizer buyout. Can he do it again?

130
130
article thumbnail

CVS Health to acquire Oak Street Health for $10.6B

Drug Store News

CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.

120
120
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Scottish biotech aims to cure common cold

Pharmafile

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae. The Livingston-based company is assessing how waste molecules from spirulina, an algae often consumed as a superfood, could be used as a cure for the common cold, COVID-19 and various other viruses.

article thumbnail

STAT+: Bayer, facing investor ire, appoints an outsider CEO

STAT

Bayer named former Roche executive Bill Anderson as its new CEO on Wednesday, potentially ending a dramatic and difficult chapter during which its current chief executive, Werner Baumann, presided over the disastrous $63 billion purchase of the agriculture firm Monsanto. Anderson will take over April 1, becoming the first American to run the 160-year-old conglomerate, which invented aspirin and later played a major role in the development of hormonal contraceptives, hemophilia clotting factors,

115
115
article thumbnail

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022

Fierce Healthcare

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022 rking Wed, 02/08/2023 - 16:01

113
113
article thumbnail

CVS Health posts strong Q4, full-year 2022 results

Drug Store News

CVS Health’s fourth quarter revenues increased to $83.8 billion up 9.5% compared to the prior year.

106
106
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Seizure drug offers hope of expanding the pool of donor hearts

STAT

The moment a donor heart is cut off from its blood supply, transplant teams are on a race against the clock to remove it, transport it, and sew it into the recipient, all within four hours. A new way of reprogramming donor hearts could give them more time. A study published Wednesday in Science Translational Medicine finds that when valproic acid, a medication to treat seizures, is infused in donor hearts, it could significantly extend — potentially double — the safe storage time o

106
106
article thumbnail

10 signs of inflammation to watch out for

The Checkup by Singlecare

At some point in your life, you have probably experienced inflammation in your body. Maybe you fell on your knee and then it swelled up. Or you might have had an allergic reaction to a food or were exposed to poison ivy that caused your skin to become inflamed. Inflammation is often caused by an injury, infection, or disease. “Inflammation is the body’s natural response to injury or infection,” says Dung Trinh, MD, owner and founder of Healthy Brain Clinic.

article thumbnail

Walgreens to hold Supplier Diversity Summit in March

Drug Store News

Walgreens is inviting diverse vendors to pitch their products at its March Supplier Diversity Summit.

105
105
article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases. In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases.

FDA 105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Novartis, Bayer marshal relief for Turkey and Syria following devastating earthquake

Fierce Pharma

Novartis, Bayer marshal relief for Turkey and Syria following devastating earthquake fkansteiner Wed, 02/08/2023 - 09:56

104
104
article thumbnail

Halo Top sweetens up desserts with light baking mixes

Drug Store News

The brand’s new light mixes contain flavors of classic baked goods but with fewer calories, the company said.

103
103
article thumbnail

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann

Fierce Pharma

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann esagonowsky Wed, 02/08/2023 - 11:28

102
102
article thumbnail

STAT+: Verily, struggling to turn profits, taps a Starbucks veteran and ‘Warcraft’ master

STAT

The newly-minted CEO of the Alphabet health tech spinout Verily is not a doctor or a Ph.D. scientist. He’s never run a top-flight lab or published a seminal paper in health care. His breakthrough executive job, far from the halls of science or medicine, was at Starbucks. But Stephen Gillett, 47, now finds himself in charge of one of the most ambitious (some would say overhyped) efforts to transform American health care with technology.

102
102
article thumbnail

With Oak Street Health deal, CVS pushes healthcare ambitions as investment in value-based care heats up

Fierce Healthcare

With Oak Street Health deal, CVS pushes healthcare ambitions as investment in value-based care heats up hlandi Wed, 02/08/2023 - 18:03

98
article thumbnail

STAT+: New funding for scientist David Sabatini draws divided reactions

STAT

Billionaire New York hedge fund manager Bill Ackman built a record of going against the grain and taking whatever flack or controversy came his way. True to form, Ackman announced last week that he and an anonymous donor had pledged $25 million over five years toward a new research lab for David Sabatini, a former star scientist from MIT and Whitehead Institute, whose career imploded in 2021 amid allegations of workplace misconduct and sexual harassment.

98
article thumbnail

CVS reports double-digit revenue growth in 2022, $4.1B in profit

Fierce Healthcare

CVS reports double-digit revenue growth in 2022, $4.

98
article thumbnail

Opinion: How formula companies continue to thwart breastfeeding

STAT

Parents around the world want what’s best for their babies. Many have heard that breastfeeding is good for their babies’ health, and most expectant mothers want to breastfeed, but many can’t attain that goal. A new series of papers published in The Lancet — of which I am a co-author — makes clear that a key reason for this is the marketing tactics of companies selling formula.

98
article thumbnail

CD19 CAR-T agents to boost blood cancer market

European Pharmaceutical Review

Research from data and analytics company GlobalData shows that the use of CD19 chimeric antigen receptor T-cell (CAR-T) agents for blood cancer is set to significantly increase between 2021-2031. GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. CD19 CAR-T agents Sam Warburton, Oncology Analyst at GlobalData explained: “the clinical and commercial landscape of CD19 CAR-T agents is expected to dramatically change ov

article thumbnail

7 Don’t-Miss Conferences for Pharmacists in 2023

Digital Pharmacist

Are you already geared up for upcoming conferences or has planning out your show attendances this year fallen by the wayside in the midst of an already-busy 2023? Whether you need opportunities for continuing education, want to explore new services, discover industry trends, or just network with other professionals like yourself, there are several shows that provide those opportunities and more!

article thumbnail

Humana, ChenMed continue an established partnership by announcing five-year network agreement

Fierce Healthcare

Humana, ChenMed continue an established partnership by announcing five-year network agreement aburky Wed, 02/08/2023 - 17:29

98
article thumbnail

Alvotech, Advanz Pharma enter commercialization agreement for Xolair biosimilar

Drug Store News

​​​​​​​Omalizumab is used to treat patients with allergic asthma, chronic spontaneous urticaria and nasal polyps.

98
article thumbnail

UnitedHealthcare rolls out new member reward program with focus on wellness

Fierce Healthcare

UnitedHealthcare rolls out new member reward program with focus on wellness pminemyer Wed, 02/08/2023 - 11:43

98
article thumbnail

FDA halts emergency use of Evusheld

Drug Store News

Data show Evusheld is unlikely to be active against certain SARS-CoV-2 variants, the FDA said.

FDA 98
article thumbnail

STAT+: CVS’ Oak Street Health acquisition continues the industry’s provider obsession

STAT

CVS Health’s $10.6 billion acquisition of Oak Street Health plants another flag in the latest era of health insurance industry consolidation — one defined by insurers moving beyond managing medical and drug benefits, and into directly providing care to people in a primary care office or at home. The financial benefits are immense for insurers that own those low-cost settings.